Citigroup Inc Exelixis, Inc. Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Citigroup Inc holds 465,031 shares of EXEL stock, worth $19.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

465,031

Previous 312,791 48.67%

Holding current value

$19.8 Million

Previous $10.4 Million 64.84%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$32.38 - $39.16 $4.93 Million - $5.96 Million	152,240 Added 48.67%	465,031 $17.2 Million
Q4 2024 Feb 12, 2025	SELL	$25.39 - $36.46 $6.94 Million - $9.97 Million	-273,437 Reduced 46.64%	312,791 $10.4 Million
Q3 2024 Nov 12, 2024	BUY	$21.96 - $27.6 $8.27 Million - $10.4 Million	376,764 Added 179.87%	586,228 $15.2 Million
Q2 2024 Aug 12, 2024	SELL	$20.34 - $23.73 $4.38 Million - $5.11 Million	-215,441 Reduced 50.7%	209,464 $4.71 Million
Q1 2024 May 10, 2024	BUY	$20.17 - $23.93 $4.28 Million - $5.07 Million	211,996 Added 99.57%	424,905 $10.1 Million
Q4 2023 Feb 09, 2024	SELL	$19.25 - $24.13 $284,341 - $356,424	-14,771 Reduced 6.49%	212,909 $5.11 Million
Q3 2023 Nov 09, 2023	BUY	$19.04 - $22.74 $637,287 - $761,130	33,471 Added 17.23%	227,680 $4.97 Million
Q2 2023 Aug 10, 2023	SELL	$18.17 - $20.48 $3.54 Million - $3.99 Million	-195,038 Reduced 50.11%	194,209 $3.71 Million
Q1 2023 May 11, 2023	BUY	$16.3 - $19.41 $1.49 Million - $1.77 Million	91,186 Added 30.59%	389,247 $7.56 Million
Q4 2022 Feb 09, 2023	SELL	$14.96 - $17.39 $2.49 Million - $2.89 Million	-166,411 Reduced 35.83%	298,061 $4.78 Million
Q3 2022 Nov 10, 2022	BUY	$15.68 - $22.27 $2.82 Million - $4 Million	179,643 Added 63.07%	464,472 $7.28 Million
Q2 2022 Aug 10, 2022	BUY	$17.44 - $23.16 $2.98 Million - $3.96 Million	171,040 Added 150.31%	284,829 $5.93 Million
Q1 2022 May 12, 2022	SELL	$17.03 - $22.67 $3.12 Million - $4.15 Million	-183,130 Reduced 61.68%	113,789 $2.58 Million
Q4 2021 Feb 10, 2022	BUY	$15.84 - $21.88 $2.18 Million - $3.01 Million	137,655 Added 86.43%	296,919 $5.43 Million
Q3 2021 Nov 10, 2021	BUY	$16.3 - $21.14 $2.6 Million - $3.37 Million	159,264 New	159,264 $3.37 Million

Others Institutions Holding EXEL

# of Institutions

613

Shares Held

257M

Call Options Held

1.57M

Put Options Held

730K

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $13.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account